Clinical Trials Directory

Trials / Unknown

UnknownNCT01265121

Sleep Apnea Syndrome on Acromegaly: Impact of the Treatment on the Carbohydrates Metabolism.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
University of Sao Paulo General Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Sleep apnea is a common situation that affects up to 80% of acromegalic patients. This disease is linked to disturbance on the carbohydrate metabolism increasing the rates of diabetes. The objective of this trial is to assess (with the euglycemic hyperinsulinemic clamp) the impact of the treatment of sleep apnea, with a continuous positive air pressure device (CPAP), on the insulin resistance.

Conditions

Interventions

TypeNameDescription
DEVICEContinuous positive air pressure device (CPAP)After titrating the air pressure during a polysomnography test, a CPAP device will be applied to the patient, during the night, for three months.
OTHERExternal nasal dilator adhesiveAn external nasal dilator adhesive will be given to patients. They will be applied on the nose and will be used for three months aiming to serve as a placebo for snoring and sleep apnea.

Timeline

Start date
2009-09-01
Primary completion
2011-04-01
Completion
2011-06-01
First posted
2010-12-22
Last updated
2010-12-22

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01265121. Inclusion in this directory is not an endorsement.